when was tirzepatide approved FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA Approves Tirzepatide (Zepbound) as
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3





:max_bytes(150000):strip_icc()/VWH-GettyImages-2273515689-58029a50a5bc4db6b30f23edc48bc997.jpg)













